Advanced search
Publication Cover
OncoTargets and Therapy Volume 11, 2018 - Issue
Submit an article Journal homepage
59
Views
34
CrossRef citations to date
0
Altmetric
Original Research

A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma

Hui Xie1 Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, People’s Republic of China;2 Department of Interventional Therapy, 302nd Hospital of People’s Liberation Army, Beijing, People’s Republic of China
,
Shengtao Tian2 Department of Interventional Therapy, 302nd Hospital of People’s Liberation Army, Beijing, People’s Republic of China
,
Haipeng Yu1 Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, People’s Republic of China
,
Xueling Yang1 Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, People’s Republic of China
,
Jia Liu3 Department of Blood Transfusion, 302nd Hospital of People’s Liberation Army, Beijing, People’s Republic of China
,
Huaming Wang2 Department of Interventional Therapy, 302nd Hospital of People’s Liberation Army, Beijing, People’s Republic of China
,
Fan Feng2 Department of Interventional Therapy, 302nd Hospital of People’s Liberation Army, Beijing, People’s Republic of ChinaCorrespondence[email protected]
&
Zhi Guo1 Department of Interventional Therapy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 3257-3265 | Published online: 31 May 2018

Citations (34)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (13)

Qing-Ping Shao, Chen Wei, Jie Yang & Wen-Zhou Zhang. (2020) miR-3609 Decelerates the Clearance of Sorafenib in Hepatocellular Carcinoma Cells by Targeting EPAS-1 and Reducing the Activation of the Pregnane X Receptor Pathway. OncoTargets and Therapy 13, pages 7213-7227.
Read now
Ying-Qi Feng, Bo-An Li, Fan Feng, Yong-Shou Chen, Yi-Xin Ren, Heng Zhang & Shuang Cao. (2020) Novel mTOR Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular Targeting Agents. OncoTargets and Therapy 13, pages 7165-7176.
Read now
Fang-jie Hou, Li-xiao Guo, Kai-yan Zheng, Jun-na Song, Qian Wang & Yu-guang Zheng. (2019) Chelidonine enhances the antitumor effect of lenvatinib on hepatocellular carcinoma cells. OncoTargets and Therapy 12, pages 6685-6697.
Read now
Yan Huo, Qun Wang, Ying Liu, Junyi Wang, Qian Li, Zongyuan Li, Yan Dong, Yifei Huang & Liqiang Wang. (2019) A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells. OncoTargets and Therapy 12, pages 6069-6082.
Read now
Hong-qing Zhou, Ming-sheng Liu, Ti-bin Deng, Ping-bo Xie, Wei Wang, Tao Shao, Yao Wu & Peng Zhang. (2019) The TGF-β/Smad Pathway Inhibitor SB431542 Enhances The Antitumor Effect Of Radiofrequency Ablation On Bladder Cancer Cells. OncoTargets and Therapy 12, pages 7809-7821.
Read now
Du Meng, Hongwei Lei, Xiaoqiang Zheng, Yaxuan Han, Ronggang Sun, Dongli Zhao & Rui Liu. (2019) A temperature-sensitive phase-change hydrogel of tamoxifen achieves the long-acting antitumor activation on breast cancer cells. OncoTargets and Therapy 12, pages 3919-3931.
Read now
Jia-Yan Ni, Hong-Liang Sun, Jiang-Hong Luo, Xiong-Ying Jiang, Dong Chen, Wei-Dong Wang, Yao-Ting Chen, Jin-Hua Huang & Lin-Feng Xu. (2019) Transarterial Chemoembolization and Sorafenib Combined with Microwave Ablation for Advanced Primary Hepatocellular Carcinoma: A Preliminary Investigation of Safety and Efficacy. Cancer Management and Research 11, pages 9939-9950.
Read now
Lin Zhu, Zhifei Liu, Ruijia Dong, Xiaojun Wang, Mingzi Zhang, Xiao Guo, Nanze Yu & Ang Zeng. (2019) MicroRNA-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375. Cancer Management and Research 11, pages 5845-5856.
Read now
Xiao Li, Wei Wang, Yi Fan, Yue Wei, Li-Qin Yu, Ji-Fu Wei & Yi-Fen Wang. (2018) Anticancer efficiency of cycloartane triterpenoid derivatives isolated from Cimicifuga yunnanensis Hsiao on triple-negative breast cancer cells. Cancer Management and Research 10, pages 6715-6729.
Read now
Yan Chen, Qinglei Zeng, Xiufang Liu, Junliang Fu, Zhen Zeng, Zhiqin Zhao, Ze Liu, Wenlin Bai, Zheng Dong, Hongjin Liu, Xiaoxia Lu, Yunfeng Zhu & Yinying Lu. (2018) LINE-1 ORF-1p enhances the transcription factor activity of pregnenolone X receptor and promotes sorafenib resistance in hepatocellular carcinoma cells. Cancer Management and Research 10, pages 4421-4438.
Read now
Yanli Wang & Zigui Tang. (2018) A novel long-sustaining system of apatinib for long-term inhibition of the proliferation of hepatocellular carcinoma cells. OncoTargets and Therapy 11, pages 8529-8541.
Read now
Du Meng, Ming Lei, Yaxuan Han, Dongli Zhao, Xiaozhi Zhang, Yunyi Yang & Rui Liu. (2018) MicroRNA-645 targets urokinase plasminogen activator and decreases the invasive growth of MDA-MB-231 triple-negative breast cancer cells. OncoTargets and Therapy 11, pages 7733-7743.
Read now
Jiaqi Li, Jing Zhao, Huan Wang, Xiaohan Li, Aixia Liu, Qin Qin & Boan Li. (2018) MicroRNA-140-3p enhances the sensitivity of hepatocellular carcinoma cells to sorafenib by targeting pregnenolone X receptor. OncoTargets and Therapy 11, pages 5885-5894.
Read now

Articles from other publishers (21)

Da Mao, Meihong Xu, Qiyu Jiang, Huiwei Sun, Fang Sun, Ruichuang Yang, Yantao Chai, Xiaojuan Li, Boan Li & Yong Li. (2022) A Single Nucleotide Mixture Enhances the Antitumor Activity of Molecular-Targeted Drugs Against Hepatocellular Carcinoma. Frontiers in Pharmacology 13.
Crossref
Baisheng Sun, Yin Long, Ling Xiao, Jiazhi Wang, Qian Yi, Dali Tong & Ke Li. (2022) Target Protein for Xklp2 Functions as Coactivator of Androgen Receptor and Promotes the Proliferation of Prostate Carcinoma Cells. Journal of Oncology 2022, pages 1-10.
Crossref
Yuan-Yuan Liu, Cheng-Zhi Ding, Jia-Ling Chen, Zheng-Shuai Wang, Bin Yang & Xiao-Ming Wu. (2022) A Novel Small Molecular Inhibitor of DNMT1 Enhances the Antitumor Effect of Radiofrequency Ablation in Lung Squamous Cell Carcinoma Cells. Frontiers in Pharmacology 13.
Crossref
Mei Luo, Huiwei Sun, Qiyu Jiang, Yantao Chai, Congshu Li, Bin Yang & Zhixian Hong. (2021) Novel Nanocrystal Injection of Insoluble Drug Anlotinib and Its Antitumor Effects on Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Xiao-zheng Zou, Jun-feng Hao & Xiu-hua Zhou. (2021) Inhibition of SREBP-1 Activation by a Novel Small-Molecule Inhibitor Enhances the Sensitivity of Hepatocellular Carcinoma Tissue to Radiofrequency Ablation. Frontiers in Oncology 11.
Crossref
Hua Yang, Mu-Zi-he Zhang, Hui-wei Sun, Yan-tao Chai, Xiaojuan Li, Qiyu Jiang & Jun Hou. (2021) A Novel Microcrystalline BAY-876 Formulation Achieves Long-Acting Antitumor Activity Against Aerobic Glycolysis and Proliferation of Hepatocellular Carcinoma. Frontiers in Oncology 11.
Crossref
Xiao-zheng Zou, Xiu-hua Zhou, Ying-qi Feng, Jun-feng Hao, Bing Liang & Meng-wei Jia. (2021) Novel inhibitor of OCT1 enhances the sensitivity of human esophageal squamous cell carcinoma cells to antitumor agents. European Journal of Pharmacology 907, pages 174222.
Crossref
Yamin Jie, Guijun Liu, Mingyan E, Ying Li, Guo Xu, Jingjing Guo, Yinyin Li, Guanghua Rong, Yongwu Li & Anxin Gu. (2021) Novel small molecule inhibitors of the transcription factor ETS-1 and their antitumor activity against hepatocellular carcinoma. European Journal of Pharmacology 906, pages 174214.
Crossref
Junxiao Wang, Rui Liu, Yun Zhao, Zhenhu Ma, Zejie Sang, Zhenyu Wen, Xueling Yang & Hui Xie. (2021) Novel Microcrystal Formulations of Sorafenib Facilitate a Long-Acting Antitumor Effect and Relieve Treatment Side Effects as Observed With Fundus Microcirculation Imaging. Frontiers in Oncology 11.
Crossref
Qiong Wu, Tian-yi Liu, Bai-chun Hu, Xiang Li, Yu-ting Wu, Xiao-tong Sun, Xiao-wen Jiang, Shu Wang, Xiao-chun Qin, Huai-wei Ding & Qing-chun Zhao. (2021) CK-3, A Novel Methsulfonyl Pyridine Derivative, Suppresses Hepatocellular Carcinoma Proliferation and Invasion by Blocking the PI3K/AKT/mTOR and MAPK/ERK Pathways. Frontiers in Oncology 11.
Crossref
Boan Li, Fan Feng, Hui Jia, Qiyu Jiang, Shuang Cao, Ling Wei, Yingshi Zhang & Jincai Lu. (2021) Rhamnetin decelerates the elimination and enhances the antitumor effect of the molecular-targeting agent sorafenib in hepatocellular carcinoma cells via the miR-148a/PXR axis . Food & Function 12:6, pages 2404-2417.
Crossref
Wei Zhou, Yongping Gao, Yaqi Tong, Qingjun Wu, Yunzhi Zhou & Yanming Li. (2021) Anlotinib enhances the antitumor activity of radiofrequency ablation on lung squamous cell carcinoma. Pharmacological Research 164, pages 105392.
Crossref
Chunzhan Wang, Shengguang Ding, Baisheng Sun, Liang Shen, Ling xiao, Zhihai Han & Haitao Huang. (2020) Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib. Pharmacological Research 161, pages 105110.
Crossref
Hua Yang, Lili Ren, Yanan Wang, Xuebing Bi, Xiaoli Li, Ming Wen, Qian Zhang, Yang Yang, Youchao Jia, Yumiao Li, Aimin Zang, Yaning wei & Guanghai Dai. (2020) FBI-1 enhanced the resistance of triple-negative breast cancer cells to chemotherapeutic agents via the miR-30c/PXR axis. Cell Death & Disease 11:10.
Crossref
Yan Ma, Ningli Chai, Qiyu Jiang, Zhengyao Chang, Yantao Chai, Xiaojuan Li, Huiwei Sun, Jun Hou & Enqiang Linghu. (2020) DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents. Pharmacological Research 160, pages 105071.
Crossref
De-bin Ma, Meng-meng Qin, Liang Shi & Xin-min Ding. (2019) MicroRNA-6077 enhances the sensitivity of patients-derived lung adenocarcinoma cells to anlotinib by repressing the activation of glucose transporter 1 pathway. Cellular Signalling 64, pages 109391.
Crossref
Huiwei Sun, Fan Feng, Hui Xie, Xiaojuan Li, Qiyu Jiang, Yantao Chai, Zhijie Wang, Ruichuang Yang, Ruisheng Li & Jun Hou. (2019) Quantitative examination of the inhibitory activation of molecular targeting agents in hepatocellular carcinoma patient‐derived cell invasion via a novel in vivo tumor model. Animal Models and Experimental Medicine 2:4, pages 259-268.
Crossref
Bin Yang, Chunping Wang, Hui Xie, Yiwu Wang, Jiagan Huang, Yihui Rong, Huixin Zhang, Huifang Kong, Yongping Yang & Yinying Lu. (2019) MicroRNA-3163 targets ADAM-17 and enhances the sensitivity of hepatocellular carcinoma cells to molecular targeted agents. Cell Death & Disease 10:10.
Crossref
Du Meng, Min Meng, Anqi Luo, Xin Jing, Guanying Wang, Shangke Huang, Minna Luo, Shan Shao, Xinhan Zhao & Rui Liu. (2018) Effects of VEGFR1+ hematopoietic progenitor cells on pre-metastatic niche formation and in vivo metastasis of breast cancer cells. Journal of Cancer Research and Clinical Oncology 145:2, pages 411-427.
Crossref
Lin Wang, Ling Zhao, Xiaomeng Jia, Lina Jiang, Yeqiong Song, Qinong Ye & Zhaohui Lyu. (2019) Aminophenols increase proliferation of thyroid tumor cells by inducing the transcription factor activity of estrogen receptor α. Biomedicine & Pharmacotherapy 109, pages 621-628.
Crossref
Yingshi Zhang, Dandan Li, Qiyu Jiang, Shuang Cao, Huiwei Sun, Yantao Chai, Xiaojuan Li, Tianshu Ren, Ruichuang Yang, Fan Feng, Bo-an Li & Qingchun Zhao. (2018) Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells. Cell Death & Disease 9:7.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.